Dusseldorf - Delayed Quote EUR
Neurocrine Biosciences Inc (NB3.DU)
103.15
-0.40
(-0.39%)
At close: 8:10:59 AM GMT+2
Loading Chart for NB3.DU
- Previous Close
103.55 - Open
103.15 - Bid --
- Ask --
- Day's Range
103.15 - 103.15 - 52 Week Range
77.08 - 147.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: NB3.DU
View MorePerformance Overview: NB3.DU
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
NB3.DU
22.68%
S&P 500 (^GSPC)
0.64%
1-Year Return
NB3.DU
20.26%
S&P 500 (^GSPC)
11.90%
3-Year Return
NB3.DU
32.41%
S&P 500 (^GSPC)
48.70%
5-Year Return
NB3.DU
1.01%
S&P 500 (^GSPC)
103.62%
Compare To: NB3.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
103.15
-0.39%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
79.52
-2.72%
Mkt Cap 5.502B
Industry Drug Manufacturers—Specialty & Generic
Statistics: NB3.DU
View MoreValuation Measures
As of 5/9/2025
Market Cap
10.21B
Enterprise Value
9.76B
Trailing P/E
39.39
Forward P/E
22.57
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.98
Price/Book (mrq)
4.53
Enterprise Value/Revenue
4.54
Enterprise Value/EBITDA
19.58
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--